Category: Finance


  • Lumber Liquidators tanking shares

    Lumber Liquidators is tanking again

    Lumber Liquidators fell by as much as 15% in early trading after the company reported a wider-than-expected first-quarter loss. At 9:30am shares in the company are down about 13%. The laminate-flooring retailer’s sales fell for the fourth straight quarter. The company has been in trouble since March. “60 Minutes” aired an episode that alleged it […]

  • Krispy Kreme Donuts

    Krispy Kreme gobbled up for $1.35 billion

    Krispy Kreme is being sold to JAB Holding, a private company, for $1.35 billion. JAB is the same company that recently agreed to buy Keurig Green Mountain. The company is being acquired by $21 a share in cash or a nearly 25% premium over Friday’s closing price. Once the deal is completed Krispy Kreme will serve […]

  • Deloitte

    Top 10 highest paying consulting firms for MBAs

    Earning an MBA pretty much guarantees a healthy salary bump, especially when it comes to lucrative industries like consulting. With increasing demand for management consultants, elite firms are willing to dole out impressive compensation packages to make sure they get the best consultants possible. In fact, the base salary for many MBA graduates at a […]

  • Goldman Sachs

    Goldman Sachs just gave the axe to more traders

    Goldman Sachs handed pink slits to traders in its securities business on Thursday, according to insiders familiar with the firings. Based on the new round of layoffs Goldman Sachs has now cut around 10% of its traders in the fix-income, currencies and commodities (FICC) business. The news was first reported by The Wall Street Journal. Goldman Sachs […]

  • Fitbit stock falls apart

    Fitbit shares are getting absolutely clobbered

    Fitbit shares collapsed by more than 17% on Thursday as the wearables manufacturer forecast second-quarter revenues that were lower than analysts expected. While earnings released on Wednesday beat expectations, the company provided guidance for the current quarter that were below even the lowest forecast. Fitbit reported adjusted earnings per share (EPS) of $0.10, beating the forecast […]

  • Peter Thiel

    Peter Thiel just sold $101 million worth of Facebook shares

    Venture Capitalist Peter Thiel, the c0-founder of PayPal and Facebook’s first institutional investor, has sold 857,626 Class A shares in Facebook. The sale has netted Thiel $101 million, according to a filing with the Securities and Exchange Commission. Thiel has been a member of Facebook’s board of directors since April 2005. The shares were sold through […]

  • Jim Chanos

    Jim Chanos is short on Valeant and Elon Musk in general

    Short-seller Jim Chanos doesn’t believe Valeant is headed for a turnaround and he also believes a few Elon Musk companies are in for trouble. The legendary short seller said on Wednesday his firm is still shorting Valeant Pharmaceuticals along with Tesla and SolarCity. “We’re still short Valeant,” Chanos said in an interview with CNBC at […]

  • PE

    Seven investments in down markets by Fortrus Financial

    “May you live in interesting times,” is an expression that is very applicable to today. International conflicts and terrorism continue to escalate while world economies rapidly slow down. We are seeing corporations see their revenues and earnings erode, quarter after quarter. Revenues have been down four straight quarters and it looks like we are heading towards a […]

  • China is buying US firms

    China is gobbling up foreign firms at a record rate

    Chinese firms are snapping up foreign companies at a record rate. Research firm Dealogic estimates that $108.5 billion in foreign deals have already occurred in 2016. There have already been 281 announced deals this year, compared to 611 for all of 2015. Last year $106 billion in total acquisitions were picked up by Chinese firms for […]

  • Bill Ackman and Valeant regrets

    Bill Ackman says there’s been a lot of ‘brain damage’ in dealing with Valeant’s board

    Activist investor Bill Ackman has admitted that he “of course” regrets investing in Valeant Pharmaceuticals and he says working with the company’s executives has been a huge pain. “There’s been a lot of brain damage in the last five weeks working with the board,” Ackman said Monday in an interview with CNBC’s Scott Wapner. Ackman joined […]